Cosomil, Inc.

📍 東京都文京区, Japan🗓 Founded 2022👥 4 employees💰 Last funded 2022
Biotechnology
LinkedIn
Cosomil, Inc. is an innovative start-up dedicated to advancing early cancer detection through the development of blood-based tests. Our groundbreaking technology, known as Single Enzyme Activity-based Protein Profiling, enables ultra-sensitive detection of enzyme activity at the single molecule level using state-of-the-art fluorescent probes and microdevices. コウソミル株式会社は、蛍光プローブとマイクロデバイスを用いて血液中の酵素の活性を1分子レベルの超高感度で検出する独自の「1分子計測リキッドバイオプシー」技術を用いて、癌等の早期疾患診断法の研究開発を行なうスタートアップ企業です。
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2022
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Japan
1
Frequently asked questions
Who invested in Cosomil, Inc.?
Cosomil, Inc. has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Cosomil, Inc. last raise funding?
The most recent investment in Cosomil, Inc. recorded on gritt.io was in 2022.
When was Cosomil, Inc. founded?
Cosomil, Inc. was founded in 2022.
What industry is Cosomil, Inc. in?
Cosomil, Inc. operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Cosomil, Inc. based?
Cosomil, Inc. is headquartered in 東京都文京区, Japan.